Abstract
Nanotechnology has attracted considerable attention in the biomedical field,
especially in cancer therapy. Nanomedicines are superior to current approaches in
cancer treatment due to their unique properties and advantages. Along this line,
nanotechnology-based therapeutics can offer greater effectiveness with minimal or no
side effects. In other words, the inherent limitations of conventional cancer therapies
have led to the development of more effective and safer treatments. In this regard, a
variety of nanocarriers have been developed for cancer treatment with high specificity,
selectivity, biocompatibility, multi-functionality, and precise sustained-release
properties. The focus of this book chapter is therefore on several advancements in
nano-based approaches and the potential applications of nanomedicines for
hematological malignancies and solid tumors with the hope of developing a robust and
efficient nanotherapeutic modality.